Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Davies, Stella M  [Clear All Filters]
2023
Odegard EA, Meeds HL, Kleiboeker SB, Ziady A, Sabulski A, Jodele S, Seif AE, Davies SM, Laskin BL, Blackard JT. BK Polyomavirus Diversity After Hematopoietic Stem Cell Transplantation. J Infect Dis. 2023.
Wang YZMichele, Taggart CB, Huber JF, Davies SM, Smith DF, Hogenesch JB, Dandoy CE. Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant. J Clin Invest. 2023;133(4).
Koo J, Ziady AG, Reynaud D, Abdullah S, Luebbering N, Kahn S, Langenberg L, Strecker L, Lake K, Dandoy CE, et al. Increased body mass index augments endothelial injury and clinical outcomes after hematopoietic stem cell transplant: Higher BMI increases endothelial injury after BMT. Transplant Cell Ther. 2023.
Wang YZM, Abdullah S, Luebbering N, Langenberg L, Duell A, Lake K, Lane A, Hils B, Silva OVázquez, Trapp M, et al. Intestinal permeability of stem cell transplant patients correlates with systemic acute phase responses and dysbiosis. Blood Adv. 2023.
Sabulski A, Abdullah S, Luebbering N, Aunins B, Castillo C, Lake K, Duell A, Strecker L, Langenberg L, Broomhead W, et al. Mechanisms of endothelial injury and transplant-associated thrombotic microangiopathy in tandem autologous hematopoietic stem cell transplant for neuroblastoma. Haematologica. 2023.
Jodele S, Dandoy CE, Aguayo-Hiraldo P, Lane A, Teusink-Cross A, Sabulski A, Mizuno K, Laskin BL, Freedman JLawrence, Davies SM. Prospective Multi-Institutional Study of Eculizumab to Treat High-Risk Stem Cell Transplant Associated TMA. Blood. 2023.
Galletta TJ, Lane A, Lutzko C, Leemhuis T, Cancelas JA, Khoury R, Wang YZM, Hanley PJ, Keller MD, Bollard CM, et al. Third party and patient-specific donor-derived virus-specific T cells demonstrate similar efficacy and safety for management of viral infections after hematopoietic stem cell transplant in children and young adults. Transplant Cell Ther. 2023.

Pages